MunaiMarkets Afinity Logo Transparent November 24 2024
Close

Possibility of RFK at HHS Sinks Ai-focused Drug Discovery Stocks - ARCHIVED

Please Share This Article:

Facebook
Email
LinkedIn
X
Pinterest
This content has been archived. It may no longer be relevant

Introduction

Robert F. Kennedy Jr. being picked by President-elect Trump to head of the Department of Health & Human Services  hit the 6 stocks in the MunAiMarkets Ai-focused micro/small-cap clinical-stage drug discovery stocks portfolio hard last week with NO constituents advancing. Below are the details:

AI-Focused Drug Discovery Stocks Portfolio: DOWN 9.6% w/e November 15th

  • +/- 10%:
    • Schrödinger (SDGR): -1.1%;
      • Area of Focus: uses its platform to discover novel molecules which it leverages to build a pipeline of its own clinical programs in addition to selling access to its platform to other pharmaceutical firms (see details here)
      • Market Capitalization: $1,350M
      • Pipeline: (see here)
    • AbCellera Biologics (ABCL): -1.9%
      • Area of Focus: searches for antibodies from natural immune responses which are then outsourced to their partners. (see details here)
      • Market Capitalization: $781M
      • Pipeline: (see here)
  • <10-15%:
  • <15-20%:
  •  < 20%:

Summary

The MunAiMarkets Ai-focused micro/small-cap clinical-stage drug discovery stocks portfolio went DOWN 9.6% w/e November 15th and is now DOWN 45.2% YTD.

Please Share This Article:

Facebook
Email
LinkedIn
X
Pinterest

Leave a Reply

Your email address will not be published. Required fields are marked *

Unlock Your Potential with a Full Partnership Offer From Lorimer Wilson

MunAiMarkets is a new leading-edge financial site and we’re looking for an individual with the time and enthusiasm to contribute 7-10 articles per week leading to full partnership in 2025 when I retire.

Join us in a unique partnership where your contributions drive success. Experience unparalleled support as you engage with industry experts. Together, we’ll cultivate growth and innovation, ensuring a lasting impact for all stakeholders involved.

INTERESTED LETS TALK

Know Someone Who May Be Interested? Please Share

Facebook
X
LinkedIn
Email